Professional Documents
Culture Documents
ANTIGENS
specically to an antibody the immunoglobulin receptor of B cells or by the T-cell receptor when complexed with MHC name arises from their ability to generate antibodies
includes sugars, lipids, intermediary metabolites, hormones, complex carbohydrates, phospholipids, nucleic acids and proteins found in surface or parts of a microbe or from the environment (e.g. food, pollen, etc)
Antigenic
Immunogenic
ALL molecules that are immunogenic are also antigenic..BUT...not all antigenic molecules are immunogenic! (Example: HAPTENS!)
antigens that by themselves do not elicit antibody production unable to induce an immune response alone but able to react with products (Abs) have the property of antigenicity but not immunogenicity (elicit immune response) NOTE: could be rendered immunogenic by covalently linking them to a carrier molecule
IMMUNOGENS (complete antigen) antigens that can elicit antibody production stimulate B and/or T cell arms of the immune
response and react with products (Abs) reacts with the products of it (Abs)
Foreigness
Recall: in order to elicit an immune response, a molecule must be recognized as NON-SELF by the biological system tolerance for SELF-antigens The greater the phylogenetic distance between two species, the greater the structural disparity between them EXAMPLE: bovine serum albumin not immunogenic to cow bt is on chicken (cow > goat > chicken)
Molecular Size
The most ACTIVE immunogens: 100,000 Da Substances with a molecular mass of
5,000-10,000 Da are poor immunogens molecular mass less than 1,000 Da have proven to be immunogenic
Lipids as Antigens
Lipids as Antigens
the development of both humoral and cell-mediated immune responses requires interaction of T-cells with antigen that has been processed and presented together with MHC molecules LARGE, INSOLUBLE macromolecules are generally more immunogenic than SMALL, SOLUBLE ones
degradative enzymes within antigen-presenting cells can degrade only proteins containing L-amino acids, polymers of D-amino acids cannot be processed
Biological System genotype of the recipient animal immunogen dosage and and route of
administration
adjuvants
Monday, June 25, 2012
generally administered parenterally = other than the GIT Subcutaneous route > Intramuscular > Intraperitoneal > Intraveous > Oral route
strongly inuence which immune organs and cell populations will be involved in the response intravenous = carried rst to the spleen subcutaneous = moves rst to local lymph nodes
Adjuvants
substances that, when mixed with an
antigen and injected with it, ENHANCE the immunogenicity of that antigen an antigen has LOW IMMUNOGENICITY or when only SMALL AMOUNTS of an antigen is available
Adjuvants
IN SUMMARY...
Parameter
Size
Increased Immunogenicity Large >10,000; best >100,000 Intermediate Subcutaneous/IM > Intraperitoneal > Complex Particulate Denatured Multiple differences Slow release Bacteria Effective
Decreased Immunogenicity Small MW<2500 High or Low Intravenous > Oral or intragastric Simple Soluble Native Few differences Rapid release No bacteria Ineffective
DEFINITION:
immunologically active regions of an immunogen that interacts with the specic antigen binding site in the variable region of the antibody molecule (PARATOPE) or to secreted antibodies
EXCELLENT FIT between epitope and paratope: based upon their 3-D interaction and non covalent union
are discrete site on the macromolecule recognized by the lymphocytes (Blymphocytes/ T-lymphocytes) NOTE: B and T cells recognize DIFFERENT epitopes on the SAME antigenic molecule THUS: the ability to function as a B-cell epitope is determined by the nature of the ANTIGEN-BINDING site of the antibody molecules DISPLAYED by B-cells
QUESTION: How will you know which fraction/ Handwritten: Yellow Paper to be submiited
Monday, June 25, 2012
Antigen Classication
T cell dependent Ags or TD much more complex than TI
Ags
usually proteins stimulate a full complement of immunoglobulins with all ve classes represented elicit an anamnestic or memory response & are present in most pathogenic organisms
Antigen Classication
T cell independent
Ags or TI
often polysaccharides
or lipopolysaccharides
capsular polysaccharide
Example: Fungi
Group of fungi Molds Yeasts
Yeasts
Fungi Aspergillus
Candida albicans Cryptococcus neoformans
Dermatophytes
Trichophyton
Galactomannan peptides
peptidofucomannan galactomannan
Paracoccodioides
galactomannan
E2 factor
Coccidioides imitis
Methyl-mannose polymer
Coccidiodin factor
Subcutaneous
Sporothrix schenckii
Peptido-L-rhamno-D-mannan
Antibody class induced Immunological memory response Present in most pathogenic microbes
Monday, June 25, 2012
NO
YES
NO
Superantigens
a substance such as a bacterial toxin capable of stimulating MANY CD4+ T lymphocytes leading to the release of relatively large quantities of cytokines that provoke pathophysiologic manifestations NOTE: Superantigens are TD antigens = THUS, Do not require phagocyte processing stimulate multiple T cells that augment a protective T & B cell response
Superantigens
Superantigens
Examples:
Staphylococcal enterotoxins (food poisoning) Staphylococcal toxic shock toxin (toxic shock syndrome) Staphylococcal exfoliating toxins (scalded skin syndrome) Streptococcal pyrogenic exotoxins (shock)
The diseases associated with exposure to superantigens are, in part, due to hyper activation of the immune system and subsequent release of biologically active cytokines by activated T cells
Mitogens
substance, often derived from plants, that causes DNA synthesis and induces blast transformation and division by mitosis Lectins, representing plant-derived mitogens or phytomitogens are used in experimental and clinical immunology to evaluate T and B lymphocyte function in vitro
Mitogens
Characteristic Concanavalin A Phytohemagglu Pokeweed (Con A) tinin (PHA) mitogen (PWM) Source Jack beans Kidney beans Pokeweed
Molecular Structure
Tetramer
Tetramer
Polymeric
Ligand
NDi-Nacetylgalactosamine acetylchitobiose
Target cell/s
T cells
T cells
Pattern Recognition
Receptors
ANTIBODIES
(Immunoglobulins or Igs)
when bound confers antigenic specicity on B-cells Common to all antibodies: structural features binds to antigen participate in effector function
Monday, June 25, 2012
Neutralize toxins Clumps cells Ppt soluble antigens Lyses cells ! phagocytosis Neutralize viruses Activate complement
Complement Activation (IgM and C3b: important by-product; binds nonmacrophages leading to phagocytosis)
IgG): induces a collection of proteins that can perforate cell membranes specically to cell and Ag-Ab complexes
many cell types have receptors for C3b (e.g. signicance: removal and killing of pathogens
Monday, June 25, 2012
Antibody-dependent cell-mediated
Cytotoxicity (ADCC): kills cells
receptor enabling the attacking cell to recognize and kill the target cell cells (e.g. virus in host cells) with the Fc receptor of many cell types can direct the cytotoxic activities of the effector cell against the target cell
Antibodies found in
serum protein fractions revealed four peaks: albumin, alpha, beta and gamma
side light chains & two identical heavy chains linked by disulde bonds amino-terminal variable region followed by a constant region
Immunoglobulin Classes
in any given antibody molecule, the constant region contains one of ve basic heavy chain sequences called isotypes the heavy chain isotype determines the class of an antibody
Immunoglobulin Classes
Antibody Classes
PROPERTIES: major serum immunoglobulins (systemic immunity) major immunoglobulin in extravascular spaces does not require antigen binding during placental
transfer (IgG2)
C1r C1 s
C1q
C1r C1 s
C1q
Activation
monomer tail piece 4th highest serum Ig B-cell surface Ig DOES NOT BIND
complement
Tail Piece
binds to basophils and mast cells (DO NOT require antigen binding)
C! 4
Allergies
MONOCLONAL ANTIBODIES
Polyclonal antibodies : arise from MANY Bcell clones and have a HETEROGENOUS collection of binding sites Monoclonal antibodies : derived from a SINGLE B-cell clone and is a HOMOGENOUS collection of binding sites
Parungao-Balolong 2010
Monday, June 25, 2012
NEXT MEETING
Innate and Adaptive Response